These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1720795)

  • 1. Tryptase and histamine release during aspirin-induced respiratory reactions.
    Bosso JV; Schwartz LB; Stevenson DD
    J Allergy Clin Immunol; 1991 Dec; 88(6):830-7. PubMed ID: 1720795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of pulmonary mast cells by bronchoalveolar allergen challenge. In vivo release of histamine and tryptase in atopic subjects with and without asthma.
    Wenzel SE; Fowler AA; Schwartz LB
    Am Rev Respir Dis; 1988 May; 137(5):1002-8. PubMed ID: 2461667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct evidence for a role of the mast cell in the nasal response to aspirin in aspirin-sensitive asthma.
    Fischer AR; Rosenberg MA; Lilly CM; Callery JC; Rubin P; Cohn J; White MV; Igarashi Y; Kaliner MA; Drazen JM
    J Allergy Clin Immunol; 1994 Dec; 94(6 Pt 1):1046-56. PubMed ID: 7798537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral aspirin challenges in asthmatic patients: a study of plasma histamine.
    Stevenson DD; Arroyave CM; Bhat KN; Tan EM
    Clin Allergy; 1976 Sep; 6(5):493-505. PubMed ID: 975490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis.
    Schwartz LB; Metcalfe DD; Miller JS; Earl H; Sullivan T
    N Engl J Med; 1987 Jun; 316(26):1622-6. PubMed ID: 3295549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Release of histamine and tryptase during continuous and interrupted cutaneous challenge with allergen in humans.
    Shalit M; Schwartz LB; von Allmen C; Atkins PC; Lavker RM; Zweiman B
    J Allergy Clin Immunol; 1990 Jul; 86(1):117-25. PubMed ID: 1695232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time course of appearance and disappearance of human mast cell tryptase in the circulation after anaphylaxis.
    Schwartz LB; Yunginger JW; Miller J; Bokhari R; Dull D
    J Clin Invest; 1989 May; 83(5):1551-5. PubMed ID: 2468689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term effects of aspirin desensitization--treatment for aspirin-sensitive rhinosinusitis-asthma.
    Sweet JM; Stevenson DD; Simon RA; Mathison DA
    J Allergy Clin Immunol; 1990 Jan; 85(1 Pt 1):59-65. PubMed ID: 2299107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cysteinyl leukotrienes overproduction and mast cell activation in aspirin-provoked bronchospasm in asthma.
    Sladek K; Szczeklik A
    Eur Respir J; 1993 Mar; 6(3):391-9. PubMed ID: 8386106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased urinary excretion of the prostaglandin D2 metabolite 9 alpha, 11 beta-prostaglandin F2 after aspirin challenge supports mast cell activation in aspirin-induced airway obstruction.
    O'Sullivan S; Dahlén B; Dahlén SE; Kumlin M
    J Allergy Clin Immunol; 1996 Aug; 98(2):421-32. PubMed ID: 8757220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The changes in plasma histamine levels after a sulpyrin inhalation test in asthmatic patients].
    Okada Y; Adachi M; Kokubu F; Takahashi T; Tanabe Y; Maeda M; Tsuji A
    Arerugi; 1989 Apr; 38(4):334-41. PubMed ID: 2476975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Release of tryptase together with histamine during the immediate cutaneous response to allergen.
    Schwartz LB; Atkins PC; Bradford TR; Fleekop P; Shalit M; Zweiman B
    J Allergy Clin Immunol; 1987 Dec; 80(6):850-5. PubMed ID: 2447144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin-sensitive rhinosinusitis asthma: a double-blind crossover study of treatment with aspirin.
    Stevenson DD; Pleskow WW; Simon RA; Mathison DA; Lumry WR; Schatz M; Zeiger RS
    J Allergy Clin Immunol; 1984 Apr; 73(4):500-7. PubMed ID: 6368649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tryptase levels in nasal-lavage fluid as an indicator of the immediate allergic response.
    Castells M; Schwartz LB
    J Allergy Clin Immunol; 1988 Sep; 82(3 Pt 1):348-55. PubMed ID: 3049743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin sensitive rhinosinusitis and asthma.
    Kowalski ML
    Allergy Proc; 1995; 16(2):77-80. PubMed ID: 7797063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mast cell effector mechanisms.
    Lane SJ; Lee TH
    J Allergy Clin Immunol; 1996 Nov; 98(5 Pt 2):S67-71; discussion S71-2. PubMed ID: 8939179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo antigen-induced cutaneous mediator release: simultaneous comparisons of histamine, tryptase, and prostaglandin D2 release and the effect of oral corticosteroid administration.
    Atkins PC; Schwartz LB; Adkinson NF; von Allmen C; Valenzano M; Zweiman B
    J Allergy Clin Immunol; 1990 Sep; 86(3 Pt 1):360-70. PubMed ID: 1698845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of tryptase and histamine release from human lung mast cells by protease inhibitors.
    He S; Xie H
    Asian Pac J Allergy Immunol; 2004 Dec; 22(4):205-12. PubMed ID: 15783133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin-sensitive rhinosinusitis/asthma: spectrum of adverse reactions to aspirin.
    Pleskow WW; Stevenson DD; Mathison DA; Simon RA; Schatz M; Zeiger RS
    J Allergy Clin Immunol; 1983 Jun; 71(6):574-9. PubMed ID: 6853926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated bronchoalveolar lavage fluid histamine levels in allergic asthmatics are associated with increased airway obstruction.
    Jarjour NN; Calhoun WJ; Schwartz LB; Busse WW
    Am Rev Respir Dis; 1991 Jul; 144(1):83-7. PubMed ID: 2064143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.